Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence

Testosterone treatment and cardiovascular and venous thromboembolism risk: what is ‘new’?

(2017) G Corona et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Consecutive Cyproterone Acetate and Estradiol Treatment in Late-Pubertal Transgender Female Adolescents

(2017) Lloyd J.W. Tack et al.   Journal of Sexual Medicine

Cross-Sex Hormones and Metabolic Parameters in Adolescents With Gender Dysphoria

(2017) Jason Jarin et al.   PEDIATRICS

A European Network for the Investigation of Gender Incongruence: Endocrine Part

(2016) M.J.H.J. Dekker et al.   Journal of Sexual Medicine

Management of polycythaemia vera: a critical review of current data

(2015) Mary F. McMullin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Complications of injectable testosterone undecanoate in routine clinical practice

(2015) T. Middleton et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study

(2015) Marco Colizzi et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate‐Specific Antigen

(2015) Alexander W. Pastuszak et al.   Sexual Medicine

Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia

(2015) Carmen Quirós et al.   Endocrinologia y Nutricion

Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence

(2014) Katrien Wierckx et al.   Journal of Sexual Medicine

Effects of Three Different Testosterone Formulations in Female‐to‐Male Transsexual Persons

(2014) Carla Pelusi et al.   Journal of Sexual Medicine

Interpreting Laboratory Results in Transgender Patients on Hormone Therapy

(2013) Tiffany K. Roberts et al.   AMERICAN JOURNAL OF MEDICINE

Venous thrombo-embolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review

(2013) H. Asscheman et al.   ANDROLOGIA

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

(2013) K Wierckx et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point

(2013) E. Bachman et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

The diagnosis and management of erythrocytosis

(2013) C. Keohane et al.   BMJ-British Medical Journal

Long‐Term Evaluation of Cross‐Sex Hormone Treatment in Transsexual Persons

(2012) Katrien Wierckx et al.   Journal of Sexual Medicine

Onset of effects of testosterone treatment and time span until maximum effects are achieved

(2011) Farid Saad et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Testosterone Suppresses Hepcidin in Men: A Potential Mechanism for Testosterone-Induced Erythrocytosis

(2010) Eric Bachman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline

(2010) Shalender Bhasin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Intramuscular Testosterone Undecanoate on Body Composition and Bone Mineral Density in Female-to-Male Transsexuals

(2010) Andreas Mueller et al.   Journal of Sexual Medicine

Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals

(2010) Prakash Chandra et al.   International Journal of Endocrinology

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells

(2009) R. T. Calado et al.   BLOOD

Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses

(2009) Mohamed B. Elamin et al.   CLINICAL ENDOCRINOLOGY

Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals

(2009) J W Jacobeit et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy

(2009) Johannes Ott et al.   FERTILITY AND STERILITY